Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

mehr ...

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 2021, Suchdauer: 0.93s

12 3 4 5 6 7 8 9 10 11 weiter »

1
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial

von Robert Bissonnette ; Ronald Vender ; Andreas Pinter ; et al.

Journal of Dermatological Treatment, Vol 36, Iss 1 (2025)

Schlagworte: Plaque psoriasis; psoriasis vulgaris; palmoplantar psoriasis; outcome measure; reliability; validity; Dermatology; RL1-803
- View full text via DOI
Merkliste

2
Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling

von Kacey L. Sachen ; Deepa Hammaker ; Indra Sarabia ; et al.

Frontiers in Immunology, Vol 16 (2025)

Schlagworte: IL-23; IL-23p19 subunit inhibitors; guselkumab; risankizumab; CD64; in vitro cellular assays; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

3
Dupilumab Treatment Up to 5 Years Shows No Clinically Meaningful Changes in Laboratory Parameters in Adults with Moderate-to-Severe Atopic Dermatitis

von Simpson, Eric L. ; Bissonnette, Robert ; Deleuran, Mette ; et al.

Advances in Therapy. 43(3):1213-1238
- Zum Volltext (via ReDI)
Merkliste

4
Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

von Eric L. Simpson ; Robert Bissonnette ; Zelma C. Chiesa Fuxench ; et al.

Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)

Schlagworte: Atopic dermatitis; head and neck; JAK inhibitor; ruxolitinib cream; Dermatology; RL1-803
- View full text via DOI
Merkliste

5
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study

von A. David Burden ; Robert Bissonnette ; Alexander A. Navarini ; et al.

Dermatology and Therapy, Vol 13, Iss 10, Pp 2279-2297 (2023)

Schlagworte: Adverse effects; Dose-finding; Palmoplantar psoriasis; Palmoplantar pustular psoriasis; Palmoplantar pustulosis; Proof-of-concept; Dermatology; RL1-803
- View full text via DOI
Merkliste

6
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials

von Bissonnette, Robert ; Albreiki, Fatima ; Ehst, Benjamin D. ; et al.

American Journal of Clinical Dermatology. 27(1):203-208
- Zum Volltext (via ReDI)
Merkliste

7
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials

von Bissonnette, Robert ; Albreiki, Fatima ; Ehst, Benjamin D. ; et al.

American Journal of Clinical Dermatology. 27(1):199-202
- Zum Volltext (via ReDI)
Merkliste

8
The Treat-to-Target Project in Atopic Dermatitis: One Year On

von Marjolein de Bruin-Weller ; Mette Deleuran ; Tilo Biedermann ; et al.

Acta Dermato-Venereologica, Vol 103 (2023)

Schlagworte: atopic dermatitis; consensus; systemic treatment; treat-to-target; Dermatology; RL1-803
- View full text via DOI
Merkliste

9
Protocol for a two-arm parallel randomized controlled trial to evaluate patient and researcher co-presentation of research results: the Scleroderma Patient-centered Intervention Network—Patients Alongside Investigators in Research-Sharing (SPIN-PAIRS) trial

von Nassar, Elsa-Lynn ; Wurz, Amanda ; Carrier, Marie-Eve ; et al.

Trials. 26(1)
- Zum Volltext in PubMed Central
Merkliste

10
Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials

von Thombs, Brett D. ; Adams, Claire ; Nassar, Elsa-Lynn ; et al.

Trials. 26(1)
- Zum Volltext in PubMed Central
Merkliste

11
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyResearch in context

von Howard Sofen ; Robert Bissonnette ; Gil Yosipovitch ; et al.

EClinicalMedicine, Vol 57, Iss , Pp 101826- (2023)

Schlagworte: Interleukin-31 receptor alpha; IL-31; Nodular prurigo; Oncostatin M receptor beta; Prurigo nodularis; Pruritus; Medicine (General); R5-920
- View full text via DOI
Merkliste

12
Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia

von Martin, Aubrey ; Shokrian, Neda ; Kelley, Kristen J. ; et al.

In Journal of Investigative Dermatology May 2026 146(5):1265-1270
- View full text via DOI
Merkliste

13
Dosimetric Outcomes of Stereotactic Body Radiation Therapy to Ultracentral Lung Tumors: Lessons From the SUNSET Trial

von Salunkhe, Rohan ; Palma, David A. ; Warner, Andrew ; et al.

In International Journal of Radiation Oncology, Biology, Physics 1 April 2026 124(5):1290-1297
- View full text via DOI
Merkliste

14
Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center Stage

von Heena Mehta ; Julianty Angsana ; Robert Bissonnette ; et al.

Frontiers in Immunology, Vol 12 (2021)

Schlagworte: monocytes; macrophages; scRNA-seq; flow cytometry (FCM); skin - immunology; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

15
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials

von Guttman-Yassky, Emma ; Kabashima, Kenji ; Worm, Margitta ; et al.

In The Lancet 3-9 January 2026 407(10523):53-66
- View full text via DOI
Merkliste

16
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis

von Stein Gold, Linda ; Bissonnette, Robert ; Forman, Seth ; et al.

American Journal of Clinical Dermatology. 26(2):275-289
- Zum Volltext (via ReDI)
Merkliste

17
NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis

von Vladimir-Andrey Gimenez-Rivera ; Harshita Patel ; Franck P. Dupuy ; et al.

Biomolecules, Vol 13, Iss 2, p 369 (2023)

Schlagworte: atopic dermatitis; thymic stromal lymphopoietin; interleukin-13; type 2 cytokines; T helper 2 and cytotoxic type 2 T cells; Staphylococcus aureus; Microbiology; QR1-502
- View full text via DOI
Merkliste

18
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies

von Marjolein De Bruin-Weller ; Tilo Biedermann ; Robert Bissonnette ; et al.

Acta Dermato-Venereologica, Vol 101, Iss 2, p adv00402 (2021)

Schlagworte: atopic dermatitis; edelphi; consensus; surveys and questionnaires; treat-to-target; systemic treatment; Dermatology; RL1-803
- View full text via DOI
Merkliste

19
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale

von Amy S Paller ; Emma Guttman-Yassky ; Katrina Abuabara ; et al.

BMJ Open, Vol 10, Iss 11 (2020)

Schlagworte: Medicine
- View full text via DOI
Merkliste

20
Hand eczema—Part 2: Prevention, management, and treatment

von Bissonnette, Robert ; Agner, Tove ; Taylor, James S. ; et al.

In Journal of the American Academy of Dermatology November 2025 93(5):1213-1224
- View full text via DOI
Merkliste

21
Hand eczema—Part 1: Epidemiology, pathogenesis, diagnosis, and work-up

von Bissonnette, Robert ; Agner, Tove ; Molin, Sonja ; et al.

In Journal of the American Academy of Dermatology November 2025 93(5):1201-1210
- View full text via DOI
Merkliste

22
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials

von Gold, Linda Stein ; Armstrong, April W ; Bissonnette, Robert ; et al.

In The Lancet 27 September-3 October 2025 406(10510):1363-1374
- View full text via DOI
Merkliste

23
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials

von Gooderham, Melinda ; Molin, Sonja ; Bissonnette, Robert ; et al.

In Journal of the American Academy of Dermatology July 2025 93(1):95-103
- View full text via DOI
Merkliste

24
Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab

von Goleva, Elena ; Berdyshev, Evgeny ; Kreimer, Simion ; et al.

In The Journal of Allergy and Clinical Immunology May 2025 155(5):1536-1546
- View full text via DOI
Merkliste

25
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag